Cytactic Secures $16 Million to Revolutionize Cyber Crisis Management

Cytactic, a pioneering platform in cyber crisis readiness and management, has raised $16 million in a seed funding round led by Evolution Equity Partners, a prominent cybersecurity venture capital fund. This investment aims to bolster Cytactic’s efforts in fortifying organizations against escalating cyber threats through innovative crisis preparedness solutions. Businesses worldwide are grappling with the…

Read More

Index Ventures Announces New Funds Totaling $2.3 Billion – a Historic Milestone for Startups

Index Ventures, a renowned global venture capital firm, has announced a landmark capital infusion of $2.3 billion across new funds, underscoring its commitment to fostering innovation and supporting visionary entrepreneurs worldwide. This investment milestone includes an $800 million venture fund and a $1.5 billion growth fund, augmenting Index Ventures’ total capital raised since inception to…

Read More

Hayden AI Raises $90 Million Led by TPG’s The Rise Fund to Advance Vision AI Solutions for Smart Cities

Hayden AI Technologies, a frontrunner in vision AI solutions tailored for smart cities, has secured a substantial $90 million in Series C funding. The round was spearheaded by The Rise Fund, the impact investing arm of TPG, alongside contributions from existing backers such as the Drawdown Fund and Autotech Ventures. This infusion of capital will…

Read More

Mantle Secures $20 Million in Series C Funding to Propel Innovation in Metal 3D Printing Technology

Mantle, a pioneer in precision metal 3D printing for tooling applications, has achieved a significant milestone with the successful closure of a $20 million Series C funding round. This latest investment, led by Schooner Capital and supported by existing investors including Fine Structure Ventures and Foundation Capital, brings Mantle’s total funding to over $61.5 million….

Read More

HepaRegeniX Secures €15 Million Series C Funding to Propel Clinical Development of HRX-215 for Liver Regeneration

HepaRegeniX GmbH, a pioneering clinical-stage biotechnology firm specializing in regenerative therapies for liver diseases, has announced the successful closure of a Series C funding round totaling €15 million. Led by Vesalius Biocapital IV and supported by existing investors including Novo Holdings, Boehringer Ingelheim Venture Fund (BIVF), and High-Tech Gründerfonds (HTGF), this investment will accelerate the…

Read More

Lekko Secures $4.5 Million Seed Round, Emerges from Stealth with Groundbreaking Dynamic Configuration Solution

Lekko Technologies Inc., founded by former Uber engineer Konrad Niemiec, has officially launched from stealth mode, backed by a robust $4.5 million seed funding round led by Addition and LUX Capital, alongside BoxGroup, SV Angel, and Abstraction Capital. Angel investors including tech luminaries Thomas Chen and Julianna Lamb further underscore the company’s emergence as a…

Read More

Pan Cancer T Secures €4.25 Million to Advance Groundbreaking T Cell Therapies

Pan Cancer T B.V., a pioneering biotech firm based in Rotterdam, the Netherlands, has successfully concluded a Seed Extension round, securing €4.25 million. This investment round includes participation from new investor InnovationQuarter, alongside continued support from existing backers such as Van Herk Ventures, Thuja Capital, Swanbridge Capital, and Erasmus MC O&O Holdings, bringing Pan Cancer…

Read More

Revolutionizing Plastic Recycling: Polystyvert Secures $16M for Sustainable Future

Polystyvert Inc., a pioneering clean technology company specializing in recycling solutions for styrenic plastics, has successfully closed the first tranche of its Series B funding, raising over $16 million. This significant investment, led by European and North American backers including Infinity Recycling, SWEN Blue Ocean, and Earth Foundry, marks a pivotal moment in Polystyvert’s mission…

Read More

Apriori Bio Receives $1.1M Funding from CEPI to Advance AI Platform for Virus Protection

Apriori Bio, a pioneering biotechnology firm, has secured a significant funding injection of US $1.1 million from CEPI (Coalition for Epidemic Preparedness Innovations) to propel its cutting-edge artificial intelligence platform, Octavia™. Designed to safeguard against rapidly-evolving viral threats, Octavia™ employs advanced machine learning to predict and counteract virus mutations, crucial for developing variant-resilient vaccines. Octavia™…

Read More

HarmonyCares Raises $200 Million to Expand In-Home Primary Care Access Nationwide

HarmonyCares, a trailblazer in value-based in-home primary care, has secured $200 million in funding to extend its innovative care model to more patients across the United States. The investment, led by General Catalyst, McKesson Ventures, and a major national payor, alongside K2 HealthVentures and existing investors, marks a significant step towards addressing the critical gap…

Read More